REDEFINING SOLUTIONS
FOR MITRAL REGURGITATION

WE’VE CREATED A NEW GENERATION OF MINIMALLY INVASIVE TECHNOLOGIES FOR STRUCTURAL HEART DISEASE

 
 
opening%252525252Bbanner.jpg
 

-----------------------------
CAUTION!
Watch out for fraudulent emails asking to install Signal or requesting fee for application – these are scams!
-----------------------------

 
Altavalve_in_heart_white.png

Introducing AltaValve™, a truly unique, SUPRA-ANNULAR Transcatheter Mitral Valve Replacement (TMVR). AltaValve is the first Mitral Regurgitation Therapy to:

EXPAND the treatable patient population
STREAMLINE the procedure and
PRESERVE critical cardiac structures

CAUTION -- Investigational device. Limited by Federal (or United States) law to investigational use.

 
 

Awards

 

Publications

First Place in Cardiovascular Research Technologies

 

Best Technology Parade Presentation

 

JACC
Transcatheter Mitral Valve Replacement With a New Supra-Annular Valve, https://doi.org/10.1016/j.jcin.2018.10.056

JACC: Case Reports
Transcatheter Mitral Valve Therapy With Novel Supra-Annular AltaValve, First Experience in the United States, https://doi.org/10.1016/j.jaccas.2019.10.034

Expert Review of Medical Devices
Device profile of the AltaValve system for transcatheter mitral valve replacement: overview of its safety and efficacy, https://doi.org/10.1080/17434440.2020.1781616

Cardiopulmonary Imaging • Original Research
MRI Evaluation of an Atrial- Anchored Transcatheter Mitral Valve Replacement Implant, https://doi.org/10.2214/AJR.19.22206

Transcatheter Mitral Valve Therapies
Chapter 17: AltaValve - A Transcatheter Mitral Valve Regurgitation Treatment Technology